Doxycycline hyclate: Difference between revisions
No edit summary |
|||
| (4 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Doxycycline hyclate}} | |||
'''''For patient information, click <u>[[Doxycycline hyclate (patient information)|here]]'''''</u>. | |||
{{CMG}}; {{AE}} {{MM}} | |||
==Overview== | |||
'''Doxycycline''' ([[International Phonetic Alphabet|IPA]] is a [[tetracycline antibiotic]] which is commonly used to treat a variety of [[infection]]s. Doxycycline product received Food and Drug Administration (United States)|US Food and Drug Administration approval in 1967.<ref name=PackageInsert>{{cite web|title=Vibramycin. HUMAN PRESCRIPTION DRUG LABEL|url=http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d6f98d3c-5a20-4cbf-9a9c-abef10b9e465#nlm34089-3|work=DailyMed|publisher=U.S. National Library of Medicine|accessdate=3 October 2013}}</ref> Other brand names include Monodox, Microdox, Periostat, Vibra-Tabs, Oracea, Doryx,<ref>{{cite news| url=http://www.bloomberg.com/news/2012-04-30/mylan-impax-win-ruling-in-doryx-generics-patent-case.html | work=Bloomberg | first1=David | last1=Voreacos | first2=Susan | last2=Decker | title=Mylan, Impax Win Ruling in Doryx Generics Patent Case | date=30 April 2012}}</ref> Vibrox, Adoxa, Doxyhexal, Doxylin, Doxoral, Doxy-1 and Atridox (topical doxycycline hyclate for [[periodontitis]]). | |||
==Category== | |||
[[Tetracycline]] | |||
==US Brand Names== | |||
DOXY 100<sup>®</sup> | |||
==FDA Package Insert== | |||
''' [[Doxycycline hyclate description|Description]]''' | |||
'''| [[Doxycycline hyclate clinical pharmacology|Clinical Pharmacology]]''' | |||
'''| [[Doxycycline hyclate microbiology|Microbiology]]''' | |||
'''| [[Doxycycline hyclate indications and usage|Indications and Usage]]''' | |||
'''| [[Doxycycline hyclate contraindications|Contraindications]]''' | |||
'''| [[Doxycycline hyclate warnings and precautions|Warnings and Precautions]]''' | |||
'''| [[Doxycycline hyclate adverse reactions|Adverse Reactions]]''' | |||
'''| [[Doxycycline hyclate drug interactions|Drug Interactions]]''' | |||
'''| [[Doxycycline hyclate overdosage|Overdosage]]''' | |||
'''| [[Doxycycline hyclate dosage and administration|Dosage and Administration]]''' | |||
'''| [[Doxycycline hyclate how supplied|How Supplied]]''' | |||
'''| [[Doxycycline hyclate labels and packages|Labels and Packages]]''' | |||
==Mechanism of Action== | |||
Doxycycline is primarily bacteriostatic and thought to exert its antimicrobial effect by the inhibition of protein synthesis. it acts by binding to the [[30S]] and [[50S]] ribosomal subunits, which impairs protein synthesis by bacteria. Doxycycline is active against a wide range of gram-positive and gram-negative organisms.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = DOXY 100 (DOXYCYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APP PHARMACEUTICALS, LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b0894010-39bd-459f-8563-cf83343105ee | publisher = | date = | accessdate}}</ref> | |||
==References== | |||
{{Reflist|2}} | |||
[[Category:Antibiotics]] | |||
[[Category:Wikinfect]] | |||
Latest revision as of 01:59, 9 January 2014
For patient information, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
Doxycycline (IPA is a tetracycline antibiotic which is commonly used to treat a variety of infections. Doxycycline product received Food and Drug Administration (United States)|US Food and Drug Administration approval in 1967.[1] Other brand names include Monodox, Microdox, Periostat, Vibra-Tabs, Oracea, Doryx,[2] Vibrox, Adoxa, Doxyhexal, Doxylin, Doxoral, Doxy-1 and Atridox (topical doxycycline hyclate for periodontitis).
Category
US Brand Names
DOXY 100®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Dosage and Administration | How Supplied | Labels and Packages
Mechanism of Action
Doxycycline is primarily bacteriostatic and thought to exert its antimicrobial effect by the inhibition of protein synthesis. it acts by binding to the 30S and 50S ribosomal subunits, which impairs protein synthesis by bacteria. Doxycycline is active against a wide range of gram-positive and gram-negative organisms.[3]
References
- ↑ "Vibramycin. HUMAN PRESCRIPTION DRUG LABEL". DailyMed. U.S. National Library of Medicine. Retrieved 3 October 2013.
- ↑ Voreacos, David; Decker, Susan (30 April 2012). "Mylan, Impax Win Ruling in Doryx Generics Patent Case". Bloomberg.
- ↑ "DOXY 100 (DOXYCYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APP PHARMACEUTICALS, LLC]". Text " accessdate" ignored (help)